Search
for
Sort by
Research 30 of 1000+
- Teriflunomide in Patients with Relapsing–Remitting Forms of Multiple Sclerosis
- Transient hair loss during treatment with dimethyl-fumarate for multiple sclerosis
- Real-World Observational Evaluation of Hair Thinning in Patients with Multiple Sclerosis Receiving Teriflunomide: Is It an Issue in Clinical Practice?
- Pooled safety and tolerability data from four placebo-controlled teriflunomide studies and extensions
- Delayed Onset of Alopecia Areata in a Patient on Ocrelizumab for Multiple Sclerosis: A Case Report
- BH14 Multiple sclerosis and alopecia areata: drug-induced alopecia areata or coexisting autoimmune phenomena?
- Teriflunomide and Its Mechanism of Action in Multiple Sclerosis
- Bolu Yöresindeki Multipl Skleroz Hastalarında Görülen Dermatolojik Bulgular
- New insights into the phenomenon of remissions and relapses in autoimmune diseases and the puzzle of benign autoantibodies in healthy individuals
- Teriflunomide: a novel oral treatment for relapsing multiple sclerosis
- Daclizumab
- Teriflunomide efficacy, safety and tolerability in patients with relapsing forms of multiple sclerosis
- Teriflunomide: A Once-daily Oral Medication for the Treatment of Relapsing Forms of Multiple Sclerosis
- Teriflunomide in multiple sclerosis: an update
- Teriflunomide (Aubagio®) for the treatment of multiple sclerosis
- Disease-Modifying Therapy in Multiple Sclerosis: Strategies For Optimizing Management
- Disease modifying agent related skin reactions in multiple sclerosis: prevention, assessment, and management
- Wider clinical applications of fumaric acid esters: A useful option in psoriasis patients with multiple sclerosis
- Pain in Multiple Sclerosis: Understanding Pathophysiology, Diagnosis, and Management Through Clinical Vignettes
- BH25 Alopecia in a patient undergoing multiple treatments for multiple sclerosis: a rare presentation and case review
- Skin Lesions in a Daclizumab-treated Patient with Multiple Sclerosis
- “Nail loss after teriflunomide treatment: A new potential adverse event”
- Alopecia Universalis in a Multiple Sclerosis Patient After Switching From Rituximab to Ocrelizumab: A Case Report
- Hair Cortisol as a Biomarker of Chronic Stress in Community-Dwelling Adults With Longstanding Multiple Sclerosis
- Tether-induced tenosynovitis: The importance of an intact skin barrier
- Reduced level of 25-hydroxyvitamin D in chronic/relapsing Alopecia Areata
- Biotin
- Case of alemtuzumab-related alopecia areata management in MS
- Teriflunomida and hair disorders
- Differential impact of environmental factors on systemic and localized autoimmunity